Ligand profile
ZINC14768406
Virtual-screening candidate from ZINC.
Bound to: KP13_02784 — DNA topoisomerase 4 subunit A
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC14768406- UniProt (similar protein)
B0VP98- Tanimoto
- 1.000
- Target protein
- KP13_02784
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.8
- −1 ≤ LogP ≤ 5 2.37
- MW ≤ 500 Da 401.4
- LogP ≤ 5 2.37
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 83.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1c(N2C[C@@H]3CCCN[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12COc1c(N2C[C@@H]3CCCN[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16-/m0/s1InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16-/m0/s1
FABPRXSRWADJSP-ZBEGNZNMSA-NFABPRXSRWADJSP-ZBEGNZNMSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- MFX
- Homolog
- B0VP98
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC14768406 →
- ZINC ZINC20 ZINC14768406 →
- UniProt UniProt B0VP98 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC14768406”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02784.
PDB 23
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).